ARTICLE | Clinical News
ADC4022: Phase I started
November 13, 2006 8:00 AM UTC
Argenta began a U.K. Phase I trial in 36 healthy volunteers to evaluate the safety and pharmacokinetics of inhaled ADC4022 given alone and in combination with marketed inhaled corticosteroids. The fir...